2019 was characterized by challenges, great achievements and exciting new opportunities for Genomma Lab. We began the year implementing Genomma’s redesigned strategic plan, led by its four key pillars, which has meaningfully improved and strengthened our business model and enabled us to achieve improved results reflecting the renewed commitment throughout our organization." He added: "We expect 2020 to again present challenges, as well as new prospects to broaden our reach and fuel future growth. We will further leverage our strong and advantaged portfolio, best in class innovation, and the excellent go-tomarket and supply capabilities for which Genomma is known. We’ll also maintain our relentless focus on growth, operational performance and people to further build value for our stakeholders, partners, employees and investors.
Chief Executive Officer
February 26, 2020